Research Diagnosis Related Groups (DRG) level LOS quality outcomes for Hillcrest Medical Center located at 1120 S Utica Ave, Tulsa, OK, 74104 & includes data from NPIs 1679652192, 1629057229
Dexur analyzed Q3 2018 (July to September 2018) Medicare claims data to benchmark length of stay (LOS) outcomes for Hillcrest Medical Center compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2018 to Sep 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 1,954 | 1,823 | ||||||||||
Surgical | 594 | 569 | ||||||||||
Non Surgical | 1,360 | 1,254 | ||||||||||
Cardiovascular | 602 | 564 | ||||||||||
General Medicine | 260 | 229 | ||||||||||
General Surgery | 172 | 157 | ||||||||||
Orthopedics | 171 | 169 | ||||||||||
Neurology | 161 | 153 | ||||||||||
Gastroenterology & Endocrinology | 144 | 140 | ||||||||||
Pulmonology | 136 | 121 | ||||||||||
Urology | 128 | 122 | ||||||||||
Psychiatry & Mental Disorders | 64 | 61 | ||||||||||
Oncology & Hematology | 53 | 45 | ||||||||||
Spine | 20 | 20 | ||||||||||
Obstetrics & Gynecology | 15 | 15 | ||||||||||
Colorectal | 14 | 14 | ||||||||||
Dermatology | 12 | 11 |
Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2018 to Sep 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Acute Myocardial Infarction | ||||||||||||
DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 282: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Heart Failure And Shock | ||||||||||||
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
Chest Pain | ||||||||||||
DRG 313: CHEST PAIN | ||||||||||||
Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Circulatory System Diagnoses | ||||||||||||
DRG 315: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Permanent Cardiac Pacemaker Implant | ||||||||||||
DRG 243: PERMANENT CARDIAC PACEMAKER IMPLANT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 242: PERMANENT CARDIAC PACEMAKER IMPLANT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Hypertension | ||||||||||||
DRG 305: HYPERTENSION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Coronary Bypass | ||||||||||||
Carotid Artery Stent Procedures | ||||||||||||
DRG 035: CAROTID ARTERY STENT PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||
DRG 219: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Syncope And Collapse | ||||||||||||
DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
Other Vascular Procedures | ||||||||||||
Other Major Cardiovascular Procedures | ||||||||||||
Percutaneous Intracardiac Procedures | ||||||||||||
DRG 274: PERCUTANEOUS INTRACARDIAC PROCEDURES W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Atherosclerosis | ||||||||||||
DRG 303: ATHEROSCLEROSIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Aortic And Heart Assist Procedures | ||||||||||||
DRG 269: AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Peripheral Vascular Disorders | ||||||||||||
Endovascular Procedures |
Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2018 to Sep 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Septicemia Or Severe Sepsis | ||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cellulitis | ||||||||||||
DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Poisoning And Toxic Effects Of Drugs | ||||||||||||
DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Signs And Symptoms | ||||||||||||
DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Aftercare | ||||||||||||
DRG 949: AFTERCARE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2018 to Sep 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Respiratory System O.R. Procedures | ||||||||||||
DRG 166: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Craniotomy And Endovascular Intracranial Procedures |
Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2018 to Sep 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Hip And Femur Procedures Except Major Joint | ||||||||||||
Aftercare, Musculoskeletal System And Connective Tissue | ||||||||||||
DRG 560: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Medical Back Problems | ||||||||||||
DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2018 to Sep 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Degenerative Nervous System Disorders | ||||||||||||
DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Transient Ischemia | ||||||||||||
DRG 069: TRANSIENT ISCHEMIA | ||||||||||||
Seizures |
Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2018 to Sep 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
G.I.Hemorrhage | ||||||||||||
DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Diabetes | ||||||||||||
Cholecystectomy | ||||||||||||
Other Digestive System Diagnoses | ||||||||||||
Disorders Of Biliary Tract |
Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2018 to Sep 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Chronic Obstructive Pulmonary Disease | ||||||||||||
DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Simple Pneumonia And Pleurisy | ||||||||||||
DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Respiratory System Diagnosis With Ventilator Support | ||||||||||||
DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | ||||||||||||
Pulmonary Edema And Respiratory Failure | ||||||||||||
DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE |
Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2018 to Sep 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Renal Failure | ||||||||||||
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Kidney And Urinary Tract Infections | ||||||||||||
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Kidney And Urinary Tract Diagnoses |
Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2018 to Sep 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Psychoses | ||||||||||||
DRG 885: PSYCHOSES | ||||||||||||
Alcohol/Drug Abuse Or Dependence | ||||||||||||
DRG 897: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Jul 2018 to Sep 2018) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Oklahoma Total Hospitalizations (Jul 2018 to Sep 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma Avg. LOS | National Total Hospitalizations (Jul 2018 to Sep 2018) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Small And Large Bowel Procedures |